"Peptide and Oligonucleotide CDMO Market Forecast: What to Expect as it Expands by 12.5% CAGR"
In addition to regulatory challenges, CDMOs are also addressing the sustainability concerns of the biopharmaceutical industry. Companies are seeking manufacturing solutions that reduce waste, improve energy efficiency, and use sustainable raw materials. As the industry continues to evolve, the ability of CDMOs to offer eco-friendly and sustainable manufacturing practices will be crucial in...
Like
1
0 Comments 0 Shares 577 Views 0 Reviews